VHL
Click for more information
7.69% 14.0¢ virax holdings limited

Ann: Prescient completes acquisition of AKTivate Therapeutics, page-2

  1. Medify
    1,173 Posts.
    lightbulb Created with Sketch. 588
    clock Created with Sketch.
    11/12/14
    17:49
    Post #: 14447112
    After selling Pathway Oncology and AKTivate to VHL for lofty sums does Paul Hopper really need/deserve to have his directorial pay doubled to $180k.
    VHL Price at posting: 13.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

RCE Recce wraps up IV UTI trial with fastest infusion times yet; key safety review inbound
right-arrow Created with Sketch.
NEWS Seek and ye shall reap reward is this week's maxim
right-arrow Created with Sketch.
FTL York Harbour signs option agreement with Firetail Resources
right-arrow Created with Sketch.
SS1 Geology is King: Sun Silver says Maverick Springs will outshine high-grade Australian mines
right-arrow Created with Sketch.
NEWS Conference preview: Sprott founder Rick Rule shares his secrets to investing in commodities
right-arrow Created with Sketch.
NEWS Money and Investing: Fixing financial mistakes in your 30s and 40s
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add VHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.